Skip to contentB
Bio Essence Corp
B
BIOEBio Essence Corp Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$27.56K-$27.56KderivedN/M vs Q4 2023 EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived$3,851N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Essence Corp · CIK 1723059 · Engraved from SEC EDGAR
Operating Cash Flowderived$423,066N/M ended Dec 31, 2024 · filed Mar 28, 2025 · 87 d after period end